Blog Posts by Tag: Laboratory
How to Reduce Retro Authorizations to Improve Reimbursement
Enjoy the following content from our partner, Infinx. The reimbursement landscape for clinical labs and remote patient monitoring has never been so challenging or so precarious. Patient and third-party payor responsibility continues to shift, and there is no end in sight for ongoing changes and increases in government regulations and insurance requirements.In a rapidly changing and consumer-...
Top 3 Challenges in Community Oncology Revenue Cycle Management
Community oncology continues to experience a dramatic shift in market dynamics. Substantive developments include a proliferation of acquisitions, the CMS Merit-Based Incentive Payment System (MIPS) and larger shift to value-based reimbursement models, as well as exploration of precision medicine as the standard of care.Notable changes that directly constrain practice financial health include fee...
You Invested to Meet the Demand for COVID-19 Testing: How Do You Optimize that Investment Post-Pandemic?
At the beginning of the COVID-19 pandemic in the U.S., many laboratories invested in equipment, supplies, and personnel to manage the surge of COVID-19 test demand. For the laboratory information system (LIS), the backbone of the laboratory IT infrastructure, this meant new workflows, report templates, and instrument interfaces to handle the new COVID-19 Polymerase Chain Reaction (PCR) tests.Once...
University of Southern California (USC) Department of Pathology and Laboratory Medicine — An Outreach Success Story
The University of Southern California (USC) Department of Pathology and Laboratory Medicine is one of the largest and most acclaimed in the country, with nationally and internationally renowned physicians on its staff. When the team at USC decided to open an outreach laboratory to expand their lab services to the community, the department chose XIFIN, Inc. as its pathology laboratory information...
4 Ways to Maximize Revenue Regarding Genetic Testing
As genetic testing has continued to increase, reimbursements on genetic test claims remain a significant challenge for clinical laboratories and anatomic pathology groups.According to Concert Genetics, the number of total genetic tests in 2012 was 10,000. By year-end 2020, that number had grown to 166,450 tests. Not only is the number of tests increasing, but the testing is becoming more...
The Value of Payor-Specific Appeals Automation
Clarisa BlattnerSenior Director MDx Support Services, XIFIN Scott BurkClient Success Manager, XIFIN The growing number of appeals and the high costs associated with them is a challenge for many laboratories and diagnostic providers. These costs are exacerbated if the laboratory uses a traditional...
Lab Week 2021: Reflection and Gratitude
Once again, Lab week is upon us. As the second year celebrating Medical Laboratory Professionals Week (MLPW) in the midst of a global pandemic, it’s worth taking a moment to celebrate all our lab professionals and pathologists. Diagnostics is such a vital piece of the healthcare puzzle, and frontline laboratorians have been visible in unprecedented ways throughout the pandemic, but it is still...
On the Road to Herd Immunity, Labs and Payors Navigate Reimbursement Hurdles
Will I get paid for this? That’s not a question anyone wants to be posing when it comes to their work. Yet for most of 2020, amid the pandemic, it was one of the most pervasive questions from diagnostic laboratories to payors. While COVID-19 diagnostic testing volumes fluctuated dramatically, laboratories faced uncertainty in getting reimbursed for processing these tests. Then, in January 2021,...
- 1 of 18
- next ›